|
1
|
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
|
J Pharmacol Exp Ther
|
2004
|
2.08
|
|
2
|
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
|
J Nucl Med
|
2003
|
1.74
|
|
3
|
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
|
J Nucl Med
|
2006
|
1.58
|
|
4
|
123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.48
|
|
5
|
Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature.
|
J Neurosci
|
2012
|
1.46
|
|
6
|
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.
|
Nucl Med Biol
|
2005
|
1.28
|
|
7
|
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
|
J Pharmacol Exp Ther
|
2008
|
1.21
|
|
8
|
Are health-care relationships important for mammography adherence in Latinas?
|
J Gen Intern Med
|
2008
|
1.13
|
|
9
|
A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
|
J Nucl Med
|
2005
|
1.01
|
|
10
|
Cultural views, language ability, and mammography use in Chinese American women.
|
Health Educ Behav
|
2009
|
0.99
|
|
11
|
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
|
Nucl Med Commun
|
2005
|
0.96
|
|
12
|
Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
|
J Nucl Med
|
2006
|
0.89
|
|
13
|
A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
|
J Nucl Med
|
2004
|
0.81
|
|
14
|
HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
|
Bioconjug Chem
|
2006
|
0.78
|
|
15
|
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
|
Bioorg Med Chem Lett
|
2011
|
0.77
|
|
16
|
Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.77
|
|
17
|
AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
|
Naunyn Schmiedebergs Arch Pharmacol
|
2015
|
0.77
|
|
18
|
An Examination of Factors Associated with Healthcare Discrimination in Latina Immigrants: The Role of Healthcare Relationships and Language.
|
J Natl Med Assoc
|
2014
|
0.75
|
|
19
|
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
|
J Med Chem
|
2007
|
0.75
|